Objective: Vertical bone loss evaluations in the Nobel Biocare Replace ® Select Tapered TM implant system in the human after one-year loading time.
INTRODUCTION
Dental missing impairs the patients' facial esthetics and produces difficulty in mastication and speech. Although common dental prostheses are able to restore the patients' esthetics and oral function, some shortcomings using them have caused patients to search for implant-supported prostheses. Decreasing treatment time and patient discomfort while achieving higher predictability and an excel-lent esthetic outcome are advantages of dental implant treatments. An approximate 100% success rate, lack of damage to the adjacent teeth, bone loss and unpleasant esthetics as common disadvantages of fixed and removable prostheses have drastically increased the use of implant treatments [1] [2] [3] [4] [5] [6] . It has been shown that osseointegration was best achieved when the implant was placed in its position using an appropriate surgical technique with the least trauma and also avoiding overheating in the preparation procedure [6] . Implants must have primary stability and should be mechanically loaded during the healing process for 2-6 months. All the above mentioned factors could affect osseointegration [7, 8] .
The clinical long-term success of the implants depends on the osseointegration and the adhesion of the soft tissues and epithelium to the titanium surfaces of the implant [9, 10] . As dental implants are exposed to the oral environment, they may be confronted with factors such as smoking or bacterial plaques. Furthermore, the keratinized mucosa width, the history of periodontal and systemic diseases, bone resorption and even the patients' age and gender are all determinants of the implant success rate [11] . Osseointegrated implants are in close contact with the bone compared to natural teeth, in which PDL collagen fibers and their position design act as a barrier against bacterial leakage. Therefore, in case of failed implants, the peri-implant tissues are susceptible to infection, which makes the incidence of different complexities possible [11] . Different indices including plaque index, gingival index, bleeding, probing pocket depth, probing attachment index and bone resorption are used to assess the health of peri-implant soft tissues [12, 13] . Marginal bone loss is evaluated by means of radiography and is directly associated with the long-term success of implant treatments. According to Albrektsson et al [14] , marginal bone level changes in the first year after implant insertion should be less than 1-1.5 mm and the ongoing annual bone loss should be less than 0.2 mm. Using Branemark System, Adell et al [15] reported a bone loss of 1.2 mm for the first year in their 15-year study. It seems that the initial marginal bone level change occurs as an adaptation of the peri-implant bone to the occlusal load [16] . A review of 13 studies that had reported on marginal bone loss occurring around Branemark implants after the first year of insertion found a mean loss of 0.93 mm, with a range of 0.4 to 1.6 mm [17]. However, it must be noted that a more definitive conclusion about the value of bone loss around implants in time requires more scientifically designed long-term investigations over a broader age range. Investigations performed about the marginal bone changes around dental implants are important not only for the functional maintenance of the implant but also for the esthetic success of the dental implants. The increased use of implant treatments among patients forced manufacturers to modify their implant systems and introduce new systems. The aim of the present study was to retrospectively evaluate bone loss in patients treated with the Nobel Biocare Replace Select Tapered TM (Nobel Biocare, Gottenborg, Sweden) implant system in a private clinic in Tehran after 1 year following implant loading.
MATERIALS AND METHODS
A total of 31 patients (14 men, 17 women; mean age, 60.39 years) receiving 170 of Nobel Biocare Replace select Tapered TM (Gottenberge, NobelBiocare, Sweden) implant systems participated in the study. The study design was approved by the research committee of Tehran Dental School. All patients were treated at a private clinic with dental implant by means of a high profile, an experienced surgeon, cooperation of an experienced surgical team and performed as recommended by the manufacturer.
The subjects had their pretreatment radiographies in their records, were free of systemic disorders effective on their peri-implant tissues, and participated in all follow-up assessments. The patients were assessed a year after abutment connection and functional loading. All patients showed acceptable periodontal status (plaque index<15). During the follow-up examinations, the marginal bone resorption around inserted implants was determined by panoramic radiography and was recorded in specific charts. The patients' age, gender, history of disease, smoking, bone quality, implant and prosthesis loading time, implant location in the maxilla and mandible (anterior and posterior sectors), the opposing teeth, implant length, and diameter were obtained from the patients' records. All implants were tapered in geometry with two Groovy and Non-groovy designs. Groovy implants had microthread in their coronal part while Nongroovy implants had been instrumented with polish surface at their coronal part. All used bone grafts were demineralized bovine bone graft materials (Bio-Oss, Switzerland, Geishtlish Co). For evaluating the influence of bone type on implant bone loss, the bone quality was recorded during the surgery with respect to the surgeon's sense and according to lekholm and zarb index. For the assessment of postoperative changes of the bone level from the time of implant placement to one year after implant exposure, conventional dental radiographs were taken at the time of follow-up investigations using OPG device (Planmeca CC, Proline, Finland) in standard exposures of 6mA and 66-68 kVp. The film used was AGFA (Belgium) and the material for processing was Tetenal. In order to measure the marginal bone loss, a line was traced from the most upper point adjacent to the implant on the crest of the alveolar bone (point A) perpendicular to the implant axis, next the lowest point located at the bone loss depth was determined as point B. By drawing, a perpendicular line from point B to the above mentioned line, point C was determined (Fig 1) . The distance between B and C points was calculated by a ruler with 1.2 magnifications in millimeters for each implant. This distance was representative of the vertical bone loss aimed at the present study (Fig. 1) . Furthermore, the bone loss was calculated at the mesial and distal sides of the implant and the most observed loss occurring in mesial or distal sides were considered as the final implant bone loss [18] . All measurements were performed by an instructed dental student and checked by another investigator under supervision of the main investigator of the study. The mean bone loss was calculated and multiple linear regression analysis was used to assess the effect of different variables on distal, mesial, and final bone losses. Pearson coefficient was used to analyze the correlation of implant bone loss with implant diameter, length and the number of used splints. The data were analyzed by SPSS 16.0 for Windows.
RESULTS
The mean number of implants received by each patient was 5.48 (range, 1-13). Three of the patients (9.7%) were smokers and five patients (16.5%) had signs of bleeding on probing. The mean time of prostheses loading was 3.53 months (range, 2-8 months). Seven (4.1%) of the implants were placed in type I bone quality, 106 (62.4%) in type II, 50 (29.4%) in type III, and finally seven (4.1%) in type IV bone quality. Twenty (11.8%) implant sites were subjected to soft tissue grafting using Bio-Oss. Eighty-seven implants (51.2%) were placed in the mandibles and 83 (48.8%) in the maxillae. Sixty implants (35.3%) were located in the anterior areas and 110 (64.7%) in the posterior regions. In the present study, 66 (38.8%), 36 (21.2%), 26 (15.3%), 26 (15.3%), 13 (7.6%) and three (1.8%) patients had implants, natural dentitions, edentulous regions, bridges, crowns, veneers in the opposing arch respectively. One hundred and fifty seven implants (92.4%) were Groovy and 16 (7.6%) were Non-groovy. The mean number of the splints was 3.79 (range, 1-11). The mean (standard deviation) distal bone loss was 0.688 mm (0.851) and 0.665 mm (0.849) at the mesial sides of studied implants. The mean overall bone loss was 0.935 mm and the most frequent values observed at distal and mesial sides was 0.905 mm in the studied implants. The mean (standard error) bone loss at the distal sides of anterior and posterior implants was 0.833 mm (0.122) and 0.609 mm (0.075), respectively. These values were 0.717 mm (0.117) and 0.636 mm (0.078) at the mesial sides of anterior and posterior implants, respectively. Furthermore, the mean overall bone loss (standard error) of implants placed at anterior and posterior regions were 1.03 mm (0.128) and 0.882 mm (0.081). The distal, mesial, and overall bone loss were measured similarly for these regions too. No significant differences were found regarding bone loss occurring at the distal and mesial sides of the mandibular and maxillary implants or the maximum bone loss, taking place at these sides between the upper and lower implants. The mean (standard error) distal bone loss of mandibular and maxillary implants were 0.759 mm (0.088) and 0.615 mm (0.097), respectively. The mean mesial bone loss of mandibular and maxillary implants was also 0.701 mm (0.088) and 0.627 mm (0.097), respectively. The mean overall bone loss was calculated as 0.966 mm (0.092) in mandibular and 0.904 mm (0.105) in maxillary upper implants. The maximum bone loss occurring at the distal and mesial sides were 0.949 mm (0.073) and 0.769 mm (0.231), respectively. Multiple linear regression showed that the implant type (Groovy and Non-groovy) does not have any significant effect on bone loss occurring at the distal or mesial sides of implants. In addition, there was no significant difference between the overall bone loss in the two implant types. The mean (standard error) bone loss at the distal sides of Groovy and Nongroovy implants was 0.694 mm (0.068) and 0.615 mm (0.241), respectively. These values were 0.688 mm (0.069) and 0.385 mm (0.14) at the mesial sides of the implants. The maximum bone loss occurring at the distal and mesial sides were 0.949 mm (0.073) and 0.769 mm (0.231), respectively. The data suggested higher insignificant bone loss for Groovy implants, especially on the mesial sides. The mean (standard error) distal bone loss of implants received by men and women were 0.632 mm (0.078) and 0.760 mm (0.11) compared to 0.589 mm (0.074) and 0.760 mm (0.114) mesial bone loss. The mean overall bone loss for implants placed in men and women was 0.842 mm (0.079) and 1.05 mm (0.120), respectively. Although women presented with higher values of bone loss, no statistically significant differences were observed in distal, mesial, and overall bone losses between men and women as shown by multiple linear regression. The mean (standard error) distal, mesial and overall bone loss for implant sites with BioOss grafts was 0.6 mm (0.234), 0.5 mm (0.17) and 0.85 mm (0.233), respectively compared to a distal bone loss of 0.7 mm (0.067), a me- The correlation between implant lengths, diameters and splint numbers with mesial, distal and overall bone losses were assessed by Pearson correlation coefficient and the results suggested no significant correlations among them (Table 1) .
DISCUSSION
As in other parts of the skeleton, human jaws demonstrate specific tendencies for progressive time-dependent bone loss, including regions rehabilitated with oral implants. Therefore, as bone-anchored prostheses could be sustained in the oral environment for a long time in life, it is important to measure bone loss occurring around oral implants [19] . The measures of clinical oral implant success include immobility of individual implants, minimal bone loss, and no persistent morbidity [20] . Therefore, it is important to study bone loss, which has occurred after different loading times following implant insertion. The present study assessed mesial, distal, and overall bone loss of the Nobel Biocare Replace ® System implants following one-year loading time inserted with a standard surgery protocol. Evaluation of the bony changes recorded on the mesial and distal surfaces of the selected functional implants were performed by intraoral radiographs after one year. Our results showed a mean distal and mesial bone loss of 0.688 mm and 0.665 mm, respectively. The mean overall bone loss of Nobel Biocare Replace ® System (the most values observed at both sides) was also estimated as 0.935 mm. Different findings were presented by authors regarding implant bone loss following different loading times. Adell et al [15] reported a mean bone loss amounting to 1.5 mm in a 1-year follow-up. According to Rismanchian and Birang, the mean bone loss was 1.08 mm at loading time and 1.43 mm after 2 years following implant insertion [21] . Hobo et al [22] reported the mean bone loss of 1-1.5 mm for the first year of implant placement, whereas Worthington showed a mean maximum bone loss of 2 mm around the implant after 1-year loading time [23] . Behneke et al [24] showed a In another study conducted by Behneke et al [25] , similar findings were presented, reporting a mean bone loss of 0.7 mm from implant insertion to loading time and 0.1 mm annual bone loss. The mean bone loss of 0.9 mm was reported for implants at loading time and 1.4 mm after 2 years following implant placement in another study [4] . On the other hand, Johansson and Ekfeldt [26] showed a mean bone loss amounting to 0.4 mm at the first year and annual following 0.1 mm rate on Branemark implants. The result of the present study was similar to the findings reported by Albrektsson et al [14] for the range of 0.9-1.6 mm bone loss in the first year following implant placement. Compared with the above-mentioned reports, the mean bone loss measured in the present study was lower for some comparisons, which can be justified in term of good oral care and using standardized surgery and treatment protocols all suggesting appropriate efficacy of Nobel Biocare Replace ® Implant System. Roccuzzo et al [27] reported the mean marginal bone loss of 0.65 mm for implants after 6 weeks loading and 0.77 mm after 12 weeks loading when comparing 68 implants subjected to initial loading with 68 implants loaded by the common technique. Salvi et al [28] reported a mean crestal bone loss of 0.57 mm for implants loaded 1 week after insertion and 0.72 mm for implants loaded after 6 weeks. Furthermore, Boronat et al [18] showed the mean marginal bone loss of 0.58 mm following 1-year loading time. Some authors studied similar brands of implant systems to achieve more generalized results diminishing the confounding effect of implant designing. In this regard, the present study was performed on tapered implants of Nober Biocare Replace ® System including two Groovy and Nongroovy designs. However, no significant differences were found in the mean bone loss occurring between the two designs, which can be attributed to the similarity of the implant system used. The finding was in contrary to the results of Karoussis et al [29] who reported implant designs as a significant determinant of peri-implantitis lesions associated with bone loss. No significant differences were found in mesial, distal, and overall bone loss regarding bone qualities at implant sites, receiving bone grafts, implant locations at anterior or posterior regions, or at maxillary or mandibular regions and the patient's gender. Furthermore, no associations were found between mesial, distal, and overall bone loss and the implants' diameter, length and the number of splints used. Similarly, some studies reported no significant different bone loss values between maxillary and mandibular implants [18, 30, 31] . Kumar et al [32] studied 1183 ITI SLA implants and observed no significant different bone loss regarding the jaw position [32] . Tamizi et al [33] showed similar bone loss values for implants placed at the maxilla and mandible. On the contrary, Penarrocha et al [34] showed more bone loss for fixtures implanted at maxilla compared to mandibular fixtures. Pham et al [35] reported more bone loss for maxillary implants than mandibular ones. The results of Wyatt and Zarb [36] were similar to the present study as no significant differences were found regarding implants placed at anterior and posterior regions; however, Boronat et al [18] showed more bone loss for posterior implants compared to the anterior ones. No significant differences were observed between different types of bone qualities in the present study. This finding is in agreement with data previously reported by Boronat et al [18] . However, Henry et al [37] observed that the greatest peri-implant bone loss occurred in the implants located in bone types III and IV (Lekholm and Zarb classification). Tawil et al [30] reported a similarly higher bone loss for type IV bone quality (mechanically weak cancellous bone) too. These differences may be interpreted with lower frequencies of type I and IV bone qualities (7 implant sites) in the present study as compared to type II and III qualities (106 and 50 sites). According to Tamizi et al [33] , implant diameter is a significant determinant of bone loss occurring around the implant with the risk of bone loss around a 3.5 mm-diameter implant to be 5.91 folds more than a 4 mm-diameter implant. Strong et al. reported more risks of bone loss for implants with lower diameters compared to those with higher diameters [38] . However, Tawil et al [30] showed similar values of bone loss for narrow and wide implants similar to the present study. Implants studied in the present study had diameters of 3.5 mm, 4.3 mm and 5 mm with tapered designs in the Nobel Biocare Replace ® System. Narrow implants with 3.5 mm or 4 mm diameters are indicated for patients faced with space limitations between the tooth and its crest, while wider implants are indicated for patients requiring additional loading or when using an implant/abutment post with higher diameter is preferred. Differences existed on the mean bone loss values reported by different authors may be attributed to the different implant designs, the surgeon's experience, the number of studied implants, oral hygiene status and practice in patients undergoing implant restorations, the time passed from implant reception, the bone quality at implant sites or different measures to assess implant treatments. Furthermore, the depth of implant insertion, rough surface towards the mucosa, in situ preparation, and immediate loading may have influence on the outcome. The critical values of bone loss following one year of implantation (osseointegration period) have been proposed to be less than 1.5 mm with the mean 0.1 mm annual rate in the following years [39] [40] [41] . In In our study, all implants were tapered in one brand name, and were placed with just a highly qualified surgeon that can express a more trustable data in comparison with the other studies results which used different implant designs and/or surgeons. The mean mesial, distal, and overall bone loss of the implants were measured less than the mentioned critical value, which may be regarded as successful. In this regard, more studies are required to assess long-term bone loss or clinical parameters such as plaque, bleeding and gingival indices after implant insertion. These investigations can provide clinicians with accurate and exact knowledge about different implant systems helping them to choose the most stable and appropriate system.
CONCLUSION
The mean overall bone loss of the Nobel Biocare Replace ® System implant after 1-year loading was 0.935 mm. Due to the critical values of 1.5 mm for bone loss after 1-year loading time, it can be concluded that Noble Biocare Replace ® System is a suitable treatment option for implant restorations in this regard; however, more studies are required to assess long-term bone loss and other clinical parameters.
